[Pharmacologic modification of cerebral activity: value of functional neuroimaging].
Chollet
F
F
INSERM U455 et Fédération de Neurologie, Hôpital Purpan, Place Baylac, 31059 Toulouse, France.
Loubinoux
I
I
Pariente
J
J
Carel
C
C
Albucher
J F
JF
Rascol
O
O
Guiraud-Chaumeil
B
B
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D001931:Brain Mapping; D002544:Cerebral Infarction / Q000503:physiopathology; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D018377:Neurotransmitter Agents / Q000378:metabolism; D010300:Parkinson Disease / Q000503:physiopathology; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000502:physiology
D018377:Neurotransmitter Agents; D017981:Receptors, Neurotransmitter